Streetbeat News

Stock Prices

CVI

Scotiabank analyst Paul Cheng downgraded CVR Energy (NYSE:CVI) from Sector Perform to Sector Underperform and reduced the price target from $28 to $25.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 7:58 pm

CVX

Scotiabank analyst Paul Cheng downgraded Chevron (NYSE:CVX) from Sector Outperform to Sector Perform and set a price target of $170.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 7:56 pm

ORLY

O'Reilly Automotive, Inc. (NASDAQ:ORLY) shares have increased over 4.5% on Tuesday, contributing to the stock's recent rally. After reaching a 52-week high in mid-November, ORLY's stock experienced a downtrend until last week. The stock has now surged, overcoming much of the resistance faced during the downtrend, but remains below the November high. The stock has also seen several price target changes in recent weeks, with targets ranging from $986 to $1150.

Portfolio Pulse from Ryan Gustafson

January 16, 2024 | 7:55 pm

APA

Scotiabank analyst Paul Cheng downgraded APA Corporation from Sector Outperform to Sector Perform and reduced the price target from $43 to $37.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 7:50 pm

AMAM

Baird analyst Joel Beatty has downgraded Ambrx Biopharma (NASDAQ:AMAM) from Outperform to Neutral and set a price target of $28. This change reflects a revised outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 7:39 pm

OGE

Ladenburg Thalmann analyst Paul Fremont has downgraded OGE Energy (NYSE:OGE) from Buy to Neutral and set a price target of $34.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 7:35 pm

VRTX

Vertex Pharmaceuticals has received FDA approval for CASGEVY, a treatment for transfusion-dependent beta thalassemia. This approval could potentially improve the company's product portfolio and market position in the treatment of this rare blood disorder.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 7:25 pm

ADAUSD

Cardano's (ADA) anticipated stablecoin Mehen (USDM) launch has been delayed from January 16, 2024, to March 16, 2024, due to issues found in an audit by Sundae Labs. The delay aims to address security concerns and future-proof the smart contracts. Cardano's price has fallen 12.1% over the past month. K33 Research released a bearish report on Cardano, suggesting selling all ADA due to a lack of meaningful activity and stablecoin support, predicting ADA could become worthless if the situation doesn't improve.

Portfolio Pulse from Khyathi Dalal

January 16, 2024 | 7:25 pm

AA

Alcoa Corp's stock (AA) is trading lower following UBS's initiation of coverage with a Sell rating and a price target of $29.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 7:23 pm

TLRY

Tilray Brands, Inc. (NASDAQ:TLRY) stock is trading higher after the U.S. government released documents indicating a review of cannabis status under federal law. The Department of Health and Human Services recommended rescheduling cannabis to Schedule III, acknowledging its medical use and lower potential for abuse compared to Schedules I and II. Additionally, Tilray received approval from Panama's Ministry of Health for medical cannabis operations. Shares are trading above the 50-day moving average but below the 52-week high.

Portfolio Pulse from Erica Kollmann

January 16, 2024 | 7:22 pm